Overview

Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study will explore efficacy and safety of Telbivudine in the fifth year of treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Novartis
Treatments:
Telbivudine